关于视网膜母细胞瘤化疗模式的最新情况:进展和挑战
Thanaporn Kritfuangfoo1, Duangnate Rojanaporn2
1Department of Ophthalmology, Vajira Hospital, Navamindradhiraj University, Bangkok 10300, Thailand; Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
|April 19, 2024
概括
化疗是治疗视网膜母细胞瘤的关键,各种输送方法可以改善眼睛和视力保护. 动脉内化疗对晚期病例有前途,提供比静脉内化疗更好的局部控制.
科学领域:
- 儿科瘤学 儿科瘤学
- 眼科医生 眼科 眼科
- 医学研究 医学研究
背景情况:
- 视网母细胞瘤治疗已经发展到优先考虑眼睛和视力保护.
- 化疗是视网膜母细胞瘤管理的基石.
- 除了传统的静脉注射化疗之外,正在探索不同的施用途径.
研究的目的:
- 为了提供一个全面的化学疗法在视网膜母细胞瘤治疗的综合审查.
- 更新各种管理途径,结果和并发症.
- 探索新兴的治疗方法和未来的方向.
主要方法:
- 审查现有关于视网膜母细胞瘤化疗的研究.
- 基于不同化疗施用途径 (IVC,IAC,静脉内膜等) 的结果分析. ) 的情况.
- 评估治疗成功率,并发症和患者的救生.
主要成果:
- 早期视网膜母细胞瘤 (A-C组) 的高成功率 (近100%),使用目前的疗法.
- 与IVC相比,动脉内化疗 (IAC) 显示了高级视网膜母细胞瘤 (D和E组) 的优越局部控制.
- 静脉内注射显示了管理玻璃体种子的潜力,可能避免核和放射治疗.
结论:
- 化疗仍然是视网膜母细胞瘤治疗的核心,基于疾病阶段和因素的量身定制策略.
- 像IAC和静脉内注射这样的先进的注射途径为特定的视网膜母细胞瘤分类提供了更好的结果.
- 对新型治疗方法和优化化疗策略的持续研究对于改善患者的治疗结果至关重要.
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K